Key takeaways
- • Severity: Major — avoid or close monitoring.
- • Mounjaro (type 2 diabetes (FDA-approved T2D)) and Glipizide (Glucotrol) (Sulfonylurea (diabetes)).
- • Clinical management: Prescribers commonly reduce or discontinue the sulfonylurea when initiating tirzepatide. Defer all dose changes to the prescriber.
- • Monitoring: Fingerstick or CGM glucose monitoring during initiation and titration. A1c every 3 months.
Mechanism
Sulfonylureas stimulate insulin release independent of glucose level, and combining them with tirzepatide's glucose-dependent insulin secretion and slowed gastric emptying substantially increases hypoglycemia risk. This is a well-documented class effect for GLP-1 receptor agonists.
Clinical management
Prescribers commonly reduce or discontinue the sulfonylurea when initiating tirzepatide. Defer all dose changes to the prescriber.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Mounjaro or Glipizide (Glucotrol).
Monitoring
Fingerstick or CGM glucose monitoring during initiation and titration. A1c every 3 months.
When to call your doctor
- Sweating, tremor, confusion
- Glucose readings below 70 mg/dL
- Loss of consciousness
- Persistent dizziness or fatigue
In emergencies — severe abdominal pain, persistent vomiting, fainting, signs of severe hypoglycemia (confusion, seizures), or signs of bleeding — call 911 or go to the nearest emergency department.
Source / FDA label citation
Mounjaro USPI Section 5.3 (Hypoglycemia with Concomitant Use of Insulin or Insulin Secretagogues)
Editorial confidence: 10/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
Common questions
Can I take Glipizide (Glucotrol) with Mounjaro?
High clinical risk — discuss with your prescriber before combining. Prescribers commonly reduce or discontinue the sulfonylurea when initiating tirzepatide. Defer all dose changes to the prescriber. Always confirm the specific plan with your prescriber — this page summarizes general pharmacology, not personal medical advice.
What's the mechanism of any Mounjaro + Glipizide (Glucotrol) interaction?
Sulfonylureas stimulate insulin release independent of glucose level, and combining them with tirzepatide's glucose-dependent insulin secretion and slowed gastric emptying substantially increases hypoglycemia risk. This is a well-documented class effect for GLP-1 receptor agonists.
What should I monitor when on Mounjaro + Glipizide (Glucotrol)?
Fingerstick or CGM glucose monitoring during initiation and titration. A1c every 3 months.
When should I call my doctor?
Contact your prescriber if you notice any of: Sweating, tremor, confusion; Glucose readings below 70 mg/dL; Loss of consciousness; Persistent dizziness or fatigue.
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.